RxDoctor Payments Data

Asia Mohsin, MD

Obstetrics & Gynecology · Friendswood, TXNPI 1760622401

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.7% of the total across 154 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 33 manufacturers reported payments, led by AbbVie at 24.3% of the total.

$3,039in general payments, 2019–2025

Across 154 payments — averaging $19.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$738
  • Astellas Pharma US Inc$350
  • Millicent US Inc$256
  • Mayne Pharma Commercial LLC$178
  • Hologic Sales And Service, LLC$152
  • Sumitomo Pharma America, Inc.$127
  • plus $1K from 27 others
$25,701in research payments, 2019–2025

Across 8 payments — averaging $3212.61 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$26K

What the payments were for

  • Food & beverage$2,81793%
  • Education$2237%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,039 in reported general payments places this provider in the 75th percentile of 3,099 obstetrics & gynecology providers in Texas.

See all obstetrics & gynecology providers in Texas →

Medicare billing

Part B allowed, 2024
$14,692
Medicare patients
42
Services billed
117

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide12$11,934
Estradiol98$7,164
ProgesteroneProgesterone, Micronized42$1,749
Estradiol (Twice Weekly)Estradiol16$1,213
DottiEstradiol12$666
Clobetasol Propionate41$635
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst14$285
Hydroxyzine Pamoate17$263
Nystatin19$223
ValacyclovirValacyclovir Hcl11$165
Fluconazole12$107
Oxybutynin Chloride13$90
Metronidazole11$40

Paid to pharmacies, not to this prescriber.

Other obstetrics & gynecology in Friendswood

See the full list for Texas →

Where these figures come from

Is this you, or does something look wrong? →